ľ¹Ï¸£ÀûÓ°ÊÓ

If we want to skip animal testing, in vitro models are not enough. We need computer models to convert laboratory data into clinical prediction outcomes

Education is a significant part of RMU. For some, it has become a full time job; we interviewed three key players of RMU education.

Dr. Riccardo Levato and Dr. Bart Spee are joining efforts to biofabricate 3D-printed liver constructs.

Irina Mancini reflects on her 3 top moments as a PhD student.

Irina Mancini reflects on women in RMU.

With the European project ENLIGHT, researchers will develop a living model of the pancreas, using a new bioprinting technique.

Two studies, coordinated by the UMC Utrecht, receive funding from zorginstituut Nederland and ZonMw via the Subsidy Scheme for Promising Care.

Moyo Kruyt has been assigned as professor of Reconstructive Skeletal Engineering at the department of Developmental Bioengineering (DBE), Twente ľ¹Ï¸£ÀûÓ°ÊÓ.

The Bionic Human: Biomaterials, (Bio)Artificial and Bioengineered Organs and Cybernetics for the Future of Regenerative Medicine

3D-JOINT: bioprinted "living implants" to regenerate cartilage after joint damage.

The RM public campaign "Nieuwe nieren" was a success!
In this campaign, we showed what regenerative medicine contribute by means of a concrete example: the kidney.

Regenerative Medicine Utrecht is awardede for its Kennisplatform (knowledge platoform) by KNAW.

Doctors from UMC Utrecht, Erasmus MC and UMC Groningen have performed the first heart transplantation after cardiac death in the Netherlands. The procedure can drastically increase the number of heart donors available nationwide every year.

The project will be led by Keita Ito, prominent RM-researcher at TU/e and UMC Utrecht in the field of biomedical engineering.

Utrecht researchers studied a washed up whale to understand human idiopathic scoliosis.

Levensechte in 3D geprinte nierbuisjes maken het mogelijk om onderzoek te doen naar nierziektes en de behandeling daarvan.

3D printed kidney tubes that closely mimic living tubes for the first time make it possible to do research into kidney diseases and their treatment.

$650,000 prize money brings much-needed dialysis upgrade closer

Cystic fibrosis (CF) is one of the most common genetic diseases worldwide and has major consequences for patients. Although treatments are available to reduce the mucus and prevent inflammation typical of the disease, CF is not yet curable. CF is not yet curable. However, a new study by the Hans Clevers group (Hubrecht Institute) in collaboration with the Jeffrey Beekman group (UMC Utrech) and Oncode Institute offers new hope.

Young Scientists in Regenerative Medicine - Iris Pennings